Open Access[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
Author(s) -
Yaru Tian,
Xiaodan Fu,
Qingling Li,
Ying Wáng,
Dan Fan,
Qin Zhou,
Weilu Kuang,
Liangfang Shen
Publication year - 2022
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr.2022.12673
Subject(s) - molecular medicine , oncogene , cancer , microrna , audience measurement , editorial board , medicine , cancer research , cell cycle , biology , bioinformatics , political science , library science , computer science , genetics , law , gene
Following the publication of this paper, it was drawn to the Editors' attention by a concerned reader that the Transwell cell migration assay data shown in Figs. 3B and 9B were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports , the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 18: 5603‑5613, 2018; DOI: 10.3892/mmr.2018.9572].